News
Guselkumab Efficacy in Crohn’s Disease Unaffected by Prior Biologic Use
Almost all patients in the biologic-inadequate response group had previously received at least one anti–tumor necrosis factor agent, and around 15...
Almost all patients in the biologic-inadequate response group had previously received at least one anti–tumor necrosis factor agent, and around 15...
Patients with IBD had a moderately increased risk for T1D and higher odds of having prior T1D than the general population.
There is some evidence to suggest that isolation is more predictive of physical health outcomes, whereas loneliness is more predictive of mental...
“Efficacy and health-related quality-of-life outcomes were maintained through 2 years of treatment,” according to the study presenter.
Today, several dietary, pharmacologic, and psychological/behavioral approaches are available to treat patients with IBS.
“I think it’ll help explain and move medicine as a whole in a direction to a greater understanding of obesity actually being a disease, how to...
Male nurses number just 12% of the profession working in clinics and hospitals, up from less than 3% in 1970.
“Medicare plans to pay us less while costs go up. You don’t have to be an economist to know that is an unsustainable trend, though one that has...
Even limited physical activity may offer protective cognitive benefits.
This guidance document allows clinicians to use a variety of NITs to start and monitor resmetirom therapy.